CMB.TECH nv CMBT
19.01
(0.03)
(0.16%)
as of 25 Sep
- Market cap
- $5.5B
- P/E
- 3.9×
Follow CMBT
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | 2.62 | — | — |
+8 more quarters Free account |
P/S ratio |
— | 1.73 | — | — | |
P/FCF ratio |
— | 5.80 | — | — | |
P/Operating CF |
— | 21.93 | — | — | |
P/B ratio |
— | 1.25 | — | — | |
Price to Tangible BV |
— | 1.34 | — | — | |
EV/Sales |
— | 4.02 | — | — | |
EV/EBITDA |
— | 6.30 | — | — | |
EV/Operating CF |
— | 18.56 | — | — | |
EV/FCF |
— | 13.44 | — | — | |
Quick Ratio |
0.70 | 0.67 | 0.44 | 0.50 | |
Current Ratio |
1.12 | 0.95 | 0.86 | 0.73 | |
Net Debt/EBITDA |
0.00 | 11.01 | 0.00 | 0.00 | |
Debt/Assets |
59.44% | 59.63% | 63.59% | 64.72% | |
Debt/Equity |
1.68 | 1.71 | 2.04 | 2.12 | |
Asset Turnover |
0.00 | 0.25 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.45 | — | 0.00 | |
Capex/Depreciation |
(0.12) | — | — | (1.65) | |
Interest Coverage |
— | 0.00 | — | — | |
Research and Development Expense of Revenue |
— | 0.00% | — | — | |
Selling, General and Administrative Expense of Revenue |
— | 3.44% | — | — | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
— | 0.00% | — | — | |
Graham Net Nets |
— | (1.29) | — | — | |
Graham Number |
— | 33.19 | — | — | |
Earnings Yield |
— | 38.18% | — | — | |
Free Cash Flow Yield |
— | 17.24% | — | — | |
Revenue per Share |
— | 2.78 | — | — | |
Operating CF per Share |
0.00 | 0.58 | — | 0.00 | |
Capex per Share |
0.00 | 0.00 | — | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.58 | — | 0.00 | |
Cash per Share |
0.00 | 0.70 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 10.14 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 10.14 | 0.00 | 0.00 | |
Free Cash Flow |
224.75 | 167.35 | — | (234.18) | |
Working Capital |
99.79 | (44.05) | (148.26) | (225.75) | |
Capital Expenditures |
(25.19) | — | — | (450.07) | |
Net Current Asset Value |
(4,787.87) | (4,738.25) | (4,869.70) | (5,220.47) | |
EV/EBIT |
— | 6.78 | — | — | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 | |
Net Profit Margin |
— | 45.69% | — | — | |
Price to Operating Income |
— | 2.93 | — | — | |
| Other line items | |||||
Average Receivables |
419.29 | 374.92 | 278.36 | 304.23 | |
Average Payables |
213.52 | 230.73 | 151.04 | 153.44 | |
Average Inventory |
89.51 | 67.16 | 51.84 | 62.52 | |
Average Assets |
8,613.63 | 8,343.96 | 6,155.31 | 5,994.81 | |
Average Common Equity |
2,836.92 | 2,782.12 | 1,907.82 | 1,824.83 |
Columns are period end dates